CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

作者: G Reifenberger , K Ichimura , V P Collins , E E Schmidt

DOI:

关键词:

摘要: Forty-six glioblastomas, 16 anaplastic astrocytomas, and 8 astrocytomas were studied for the loss of CDKN2 (p16/MTS1) gene on 9p. The locus was homozygously deleted in 19 46 glioblastomas (41%) 1 allele lost an additional 13 cases (28%). regions limited centromerically some by MTS2 telomerically 1063.7 locus. 3 (19%) 2 further showed allele. Amplification CDK4 present 7 14 (50%) 11 (27%) with no losses at as well 32 (6%) losses. Thus one or more these two genes shown to be aberrant 85% 50% astrocytomas. None abnormalities genes.

参考文章(12)
Ichimura K, Schmidt Ee, Yamaguchi N, James Cd, Collins Vp, A Common Region of Homozygous Deletion in Malignant Human Gliomas Lies between the IFNα/ω Gene Cluster and the D9S171 Locus Cancer Research. ,vol. 54, pp. 3127- 3130 ,(1994)
Tetsuro Nishihira, Shozo Mori, Koh Miura, Yusuke Nakamura, Takahisa Aoki, Takahiro Mori, Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Research. ,vol. 54, pp. 3396- 3397 ,(1994)
Darell D. Bigner, Dennis E. Bullard, Joachim Mark, Peter C. Burger, Lawrence H. Muhlbaier, Sandra H. Bigner, M. Stephen Mahaley, Specific Chromosomal Abnormalities in Malignant Human Gliomas Cancer Research. ,vol. 48, pp. 405- 411 ,(1988)
Christopher J. Hussussian, Jeffery P. Struewing, Alisa M. Goldstein, Paul A. T. Higgins, Delphine S. Ally, Michelle D. Sheahan, Wallace H. Clark, Margaret A. Tucker, Nicholas C. Dracopoli, Germline p16 mutations in familial melanoma. Nature Genetics. ,vol. 8, pp. 15- 21 ,(1994) , 10.1038/NG0994-15
R. Day, B. Johnson, M. Skolnick, A Kamb, N. Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S. Tavtigian, E Stockert, A cell cycle regulator potentially involved in genesis of many tumor types Science. ,vol. 264, pp. 436- 440 ,(1994) , 10.1126/SCIENCE.8153634
Tsutomu Nobori, Kaoru Miura, David J. Wu, Augusto Lois, Kenji Takabayashi, Dennis A. Carson, Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature. ,vol. 368, pp. 753- 756 ,(1994) , 10.1038/368753A0
N. Hayashi, Y. Sugimoto, E. Tsuchiya, M. Ogawa, Y. Nakamura, Somatic Mutations of the MTS (Multiple Tumor Suppressor) 1/CDK41 (Cyclin-Dependent Kinase-4 Inhibitor) Gene in Human Primary Non-small Cell Lung Carcinomas Biochemical and Biophysical Research Communications. ,vol. 202, pp. 1426- 1430 ,(1994) , 10.1006/BBRC.1994.2090
Carlos Caldas, Stephan A Hahn, Luis T da Costa, Mark S Redston, Mieke Schutte, Albert B Seymour, Craig L Weinstein, Ralph H Hruban, Charles J Yeo, Scott E Kern, None, Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics. ,vol. 8, pp. 27- 32 ,(1994) , 10.1038/NG0994-27
Manual Serrano, Gregory J. Hannon, David Beach, A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature. ,vol. 366, pp. 704- 707 ,(1993) , 10.1038/366704A0
Charles H. Spruck, Mirella Gonzalez-Zulueta, Atsuko Shibata, Anne R. Simoneau, Ming-Fong Lin, Felicidad Gonzales, Yvonne C. Tsai, Peter A. Jones, P16 gene in uncultured tumours Nature. ,vol. 370, pp. 183- 184 ,(1994) , 10.1038/370183A0